Myriad Genetics sues Aliso Viejo company Ambry Genetics over gene tests
12 Jul 2013
Myriad Genetics, a biotech company, owns patents on the BRCA1 and BRCA2 genes, mutations of which help to increase the risk of certain breast and ovarian cancers. The Association for Molecular Pathology filed a suit against Myriad in 2009, claiming that the genes, which are naturally occurring segments of DNA, are not eligible for a...